About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Global Drug Discovery Outsourcing Market Size, Industry Share to 2030
Drug Discovery Outsourcing Market

Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report  By Workflow (Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, Other Associated Workflow),  By Therapeutics Area (Respiratory System, Pain and Anesthesia, Oncology, Ophthalmology, Hematology, Cardiovascular, Endocrine, Gastrointestinal, Immunomodulation, Anti-Infective, Central Nervous System, Dermatology, Genitourinary System),  By Drug Type (Small Molecules, Large Molecules (Biopharmaceuticals)) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRHI3033DR
Author : Debashree Bora
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Drug Discovery Outsourcing Market Introduction
    2.  By Workflow
      1. Introduction
        1.  Workflow By Value
      2. Target Identification & Screening
        1. By Value
      3. Target Validation & Functional Informatics
        1. By Value
      4. Lead Identification & Candidate Optimization
        1. By Value
      5. Preclinical Development
        1. By Value
      6. Other Associated Workflow
        1. By Value
    3.  By Therapeutics Area
      1. Introduction
        1.  Therapeutics Area By Value
      2. Respiratory System
        1. By Value
      3. Pain and Anesthesia, Oncology
        1. By Value
      4. Ophthalmology
        1. By Value
      5. Hematology
        1. By Value
      6. Cardiovascular
        1. By Value
      7. Endocrine
        1. By Value
      8. Gastrointestinal
        1. By Value
      9. Immunomodulation
        1. By Value
      10. Anti-Infective
        1. By Value
      11. Central Nervous System
        1. By Value
      12. Dermatology
        1. By Value
      13. Genitourinary System
        1. By Value
    4.  By Drug Type
      1. Introduction
        1.  Drug Type By Value
      2. Small Molecules
        1. By Value
      3. Large Molecules (Biopharmaceuticals)
        1. By Value
    1. Introduction
    2.  By Workflow
      1. Introduction
        1.  Workflow By Value
      2. Target Identification & Screening
        1. By Value
      3. Target Validation & Functional Informatics
        1. By Value
      4. Lead Identification & Candidate Optimization
        1. By Value
      5. Preclinical Development
        1. By Value
      6. Other Associated Workflow
        1. By Value
    3.  By Therapeutics Area
      1. Introduction
        1.  Therapeutics Area By Value
      2. Respiratory System
        1. By Value
      3. Pain and Anesthesia, Oncology
        1. By Value
      4. Ophthalmology
        1. By Value
      5. Hematology
        1. By Value
      6. Cardiovascular
        1. By Value
      7. Endocrine
        1. By Value
      8. Gastrointestinal
        1. By Value
      9. Immunomodulation
        1. By Value
      10. Anti-Infective
        1. By Value
      11. Central Nervous System
        1. By Value
      12. Dermatology
        1. By Value
      13. Genitourinary System
        1. By Value
    4.  By Drug Type
      1. Introduction
        1.  Drug Type By Value
      2. Small Molecules
        1. By Value
      3. Large Molecules (Biopharmaceuticals)
        1. By Value
    5. U.S.
      1.  By Workflow
        1. Introduction
          1.  Workflow By Value
        2. Target Identification & Screening
          1. By Value
        3. Target Validation & Functional Informatics
          1. By Value
        4. Lead Identification & Candidate Optimization
          1. By Value
        5. Preclinical Development
          1. By Value
        6. Other Associated Workflow
          1. By Value
      2.  By Therapeutics Area
        1. Introduction
          1.  Therapeutics Area By Value
        2. Respiratory System
          1. By Value
        3. Pain and Anesthesia, Oncology
          1. By Value
        4. Ophthalmology
          1. By Value
        5. Hematology
          1. By Value
        6. Cardiovascular
          1. By Value
        7. Endocrine
          1. By Value
        8. Gastrointestinal
          1. By Value
        9. Immunomodulation
          1. By Value
        10. Anti-Infective
          1. By Value
        11. Central Nervous System
          1. By Value
        12. Dermatology
          1. By Value
        13. Genitourinary System
          1. By Value
      3.  By Drug Type
        1. Introduction
          1.  Drug Type By Value
        2. Small Molecules
          1. By Value
        3. Large Molecules (Biopharmaceuticals)
          1. By Value
    6. Canada
    1. Introduction
    2.  By Workflow
      1. Introduction
        1.  Workflow By Value
      2. Target Identification & Screening
        1. By Value
      3. Target Validation & Functional Informatics
        1. By Value
      4. Lead Identification & Candidate Optimization
        1. By Value
      5. Preclinical Development
        1. By Value
      6. Other Associated Workflow
        1. By Value
    3.  By Therapeutics Area
      1. Introduction
        1.  Therapeutics Area By Value
      2. Respiratory System
        1. By Value
      3. Pain and Anesthesia, Oncology
        1. By Value
      4. Ophthalmology
        1. By Value
      5. Hematology
        1. By Value
      6. Cardiovascular
        1. By Value
      7. Endocrine
        1. By Value
      8. Gastrointestinal
        1. By Value
      9. Immunomodulation
        1. By Value
      10. Anti-Infective
        1. By Value
      11. Central Nervous System
        1. By Value
      12. Dermatology
        1. By Value
      13. Genitourinary System
        1. By Value
    4.  By Drug Type
      1. Introduction
        1.  Drug Type By Value
      2. Small Molecules
        1. By Value
      3. Large Molecules (Biopharmaceuticals)
        1. By Value
    5. U.K.
      1.  By Workflow
        1. Introduction
          1.  Workflow By Value
        2. Target Identification & Screening
          1. By Value
        3. Target Validation & Functional Informatics
          1. By Value
        4. Lead Identification & Candidate Optimization
          1. By Value
        5. Preclinical Development
          1. By Value
        6. Other Associated Workflow
          1. By Value
      2.  By Therapeutics Area
        1. Introduction
          1.  Therapeutics Area By Value
        2. Respiratory System
          1. By Value
        3. Pain and Anesthesia, Oncology
          1. By Value
        4. Ophthalmology
          1. By Value
        5. Hematology
          1. By Value
        6. Cardiovascular
          1. By Value
        7. Endocrine
          1. By Value
        8. Gastrointestinal
          1. By Value
        9. Immunomodulation
          1. By Value
        10. Anti-Infective
          1. By Value
        11. Central Nervous System
          1. By Value
        12. Dermatology
          1. By Value
        13. Genitourinary System
          1. By Value
      3.  By Drug Type
        1. Introduction
          1.  Drug Type By Value
        2. Small Molecules
          1. By Value
        3. Large Molecules (Biopharmaceuticals)
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2.  By Workflow
      1. Introduction
        1.  Workflow By Value
      2. Target Identification & Screening
        1. By Value
      3. Target Validation & Functional Informatics
        1. By Value
      4. Lead Identification & Candidate Optimization
        1. By Value
      5. Preclinical Development
        1. By Value
      6. Other Associated Workflow
        1. By Value
    3.  By Therapeutics Area
      1. Introduction
        1.  Therapeutics Area By Value
      2. Respiratory System
        1. By Value
      3. Pain and Anesthesia, Oncology
        1. By Value
      4. Ophthalmology
        1. By Value
      5. Hematology
        1. By Value
      6. Cardiovascular
        1. By Value
      7. Endocrine
        1. By Value
      8. Gastrointestinal
        1. By Value
      9. Immunomodulation
        1. By Value
      10. Anti-Infective
        1. By Value
      11. Central Nervous System
        1. By Value
      12. Dermatology
        1. By Value
      13. Genitourinary System
        1. By Value
    4.  By Drug Type
      1. Introduction
        1.  Drug Type By Value
      2. Small Molecules
        1. By Value
      3. Large Molecules (Biopharmaceuticals)
        1. By Value
    5. China
      1.  By Workflow
        1. Introduction
          1.  Workflow By Value
        2. Target Identification & Screening
          1. By Value
        3. Target Validation & Functional Informatics
          1. By Value
        4. Lead Identification & Candidate Optimization
          1. By Value
        5. Preclinical Development
          1. By Value
        6. Other Associated Workflow
          1. By Value
      2.  By Therapeutics Area
        1. Introduction
          1.  Therapeutics Area By Value
        2. Respiratory System
          1. By Value
        3. Pain and Anesthesia, Oncology
          1. By Value
        4. Ophthalmology
          1. By Value
        5. Hematology
          1. By Value
        6. Cardiovascular
          1. By Value
        7. Endocrine
          1. By Value
        8. Gastrointestinal
          1. By Value
        9. Immunomodulation
          1. By Value
        10. Anti-Infective
          1. By Value
        11. Central Nervous System
          1. By Value
        12. Dermatology
          1. By Value
        13. Genitourinary System
          1. By Value
      3.  By Drug Type
        1. Introduction
          1.  Drug Type By Value
        2. Small Molecules
          1. By Value
        3. Large Molecules (Biopharmaceuticals)
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2.  By Workflow
      1. Introduction
        1.  Workflow By Value
      2. Target Identification & Screening
        1. By Value
      3. Target Validation & Functional Informatics
        1. By Value
      4. Lead Identification & Candidate Optimization
        1. By Value
      5. Preclinical Development
        1. By Value
      6. Other Associated Workflow
        1. By Value
    3.  By Therapeutics Area
      1. Introduction
        1.  Therapeutics Area By Value
      2. Respiratory System
        1. By Value
      3. Pain and Anesthesia, Oncology
        1. By Value
      4. Ophthalmology
        1. By Value
      5. Hematology
        1. By Value
      6. Cardiovascular
        1. By Value
      7. Endocrine
        1. By Value
      8. Gastrointestinal
        1. By Value
      9. Immunomodulation
        1. By Value
      10. Anti-Infective
        1. By Value
      11. Central Nervous System
        1. By Value
      12. Dermatology
        1. By Value
      13. Genitourinary System
        1. By Value
    4.  By Drug Type
      1. Introduction
        1.  Drug Type By Value
      2. Small Molecules
        1. By Value
      3. Large Molecules (Biopharmaceuticals)
        1. By Value
    5. UAE
      1.  By Workflow
        1. Introduction
          1.  Workflow By Value
        2. Target Identification & Screening
          1. By Value
        3. Target Validation & Functional Informatics
          1. By Value
        4. Lead Identification & Candidate Optimization
          1. By Value
        5. Preclinical Development
          1. By Value
        6. Other Associated Workflow
          1. By Value
      2.  By Therapeutics Area
        1. Introduction
          1.  Therapeutics Area By Value
        2. Respiratory System
          1. By Value
        3. Pain and Anesthesia, Oncology
          1. By Value
        4. Ophthalmology
          1. By Value
        5. Hematology
          1. By Value
        6. Cardiovascular
          1. By Value
        7. Endocrine
          1. By Value
        8. Gastrointestinal
          1. By Value
        9. Immunomodulation
          1. By Value
        10. Anti-Infective
          1. By Value
        11. Central Nervous System
          1. By Value
        12. Dermatology
          1. By Value
        13. Genitourinary System
          1. By Value
      3.  By Drug Type
        1. Introduction
          1.  Drug Type By Value
        2. Small Molecules
          1. By Value
        3. Large Molecules (Biopharmaceuticals)
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2.  By Workflow
      1. Introduction
        1.  Workflow By Value
      2. Target Identification & Screening
        1. By Value
      3. Target Validation & Functional Informatics
        1. By Value
      4. Lead Identification & Candidate Optimization
        1. By Value
      5. Preclinical Development
        1. By Value
      6. Other Associated Workflow
        1. By Value
    3.  By Therapeutics Area
      1. Introduction
        1.  Therapeutics Area By Value
      2. Respiratory System
        1. By Value
      3. Pain and Anesthesia, Oncology
        1. By Value
      4. Ophthalmology
        1. By Value
      5. Hematology
        1. By Value
      6. Cardiovascular
        1. By Value
      7. Endocrine
        1. By Value
      8. Gastrointestinal
        1. By Value
      9. Immunomodulation
        1. By Value
      10. Anti-Infective
        1. By Value
      11. Central Nervous System
        1. By Value
      12. Dermatology
        1. By Value
      13. Genitourinary System
        1. By Value
    4.  By Drug Type
      1. Introduction
        1.  Drug Type By Value
      2. Small Molecules
        1. By Value
      3. Large Molecules (Biopharmaceuticals)
        1. By Value
    5. Brazil
      1.  By Workflow
        1. Introduction
          1.  Workflow By Value
        2. Target Identification & Screening
          1. By Value
        3. Target Validation & Functional Informatics
          1. By Value
        4. Lead Identification & Candidate Optimization
          1. By Value
        5. Preclinical Development
          1. By Value
        6. Other Associated Workflow
          1. By Value
      2.  By Therapeutics Area
        1. Introduction
          1.  Therapeutics Area By Value
        2. Respiratory System
          1. By Value
        3. Pain and Anesthesia, Oncology
          1. By Value
        4. Ophthalmology
          1. By Value
        5. Hematology
          1. By Value
        6. Cardiovascular
          1. By Value
        7. Endocrine
          1. By Value
        8. Gastrointestinal
          1. By Value
        9. Immunomodulation
          1. By Value
        10. Anti-Infective
          1. By Value
        11. Central Nervous System
          1. By Value
        12. Dermatology
          1. By Value
        13. Genitourinary System
          1. By Value
      3.  By Drug Type
        1. Introduction
          1.  Drug Type By Value
        2. Small Molecules
          1. By Value
        3. Large Molecules (Biopharmaceuticals)
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Drug Discovery Outsourcing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Curia
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. EVOTEC
    3. Laboratory Corporation of America Holdings
    4. GenScript
    5. Pharmaceutical Product Development LLC
    6. Charles River Laboratories
    7. Thermo Fischer ScientificInc.
    8. Merck & Co.Inc.
    9. Oncodesign
    10. Jubilant Biosys.
    11. Qiagen and Discover Corporation. 
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global cancer immunotherapy drug discovery outsourcing market size was valued at USD 1.04 billion in 2021 and is predicted to reach at USD 3.33 billion by 2030, increasing at a CAGR of 13.79% from 2022 to 2030. It is possible to outsource the re
Buy Now
Global Report
Drug Discovery Market Size The global drug discovery market size was valued at USD 24.84 billion in 2024 and is projected to reach from USD 28.98 billion in 2025 to USD 62.10 billion by 2033, growing at a CAGR of 14.90% during the forecast peri
Buy Now
Global Report
The Global Drug Discovery Service Market size was valued at USD 9649.12 million in 2019 and is expected to grow at 14.0% CAGR during the forecast period. Drug discovery is the process of designing a new drug by employing various methods such as mole
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright . All rights Reserved.